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Interfcrons are known to potentiatc various biological effects of tumor necrosis factor (TNF). Recently, two different ypes ofTNF receptors with 
molecular masses of GO kDa (pG0) and 80 kDa (pt?O), primarily expressed by epithelial cells and mycloid cells, respectively, have been identified. 
In the present report, we examined the effect of interferon-y (IFN-r) on each type of TNF receptor. Our results indiwte that IFN-y induces TNF 
receptors on both myeloid (e.g. HL-60) and epithclitil cells (e.g. H&a). Furthermore. by using antibodies pecific to each type of receptor, WC 
demonstrate that both TNF receptors are equally inducible by IFN-I, IFN-j and IFN-y. Thus, the increase in TNF receptors by interferons may 
play a role in their synergistic ellular response. 
Tumor necrosis factor; Interferon: TNF receptor 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Human tumor necrosis factor (TNF) exhibits a wide 
variety of biological activities in vitro including antipro- 
liferation of tumor cells, proliferation of normal human 
fibroblasts, Et cells, and thymocytes, antiviral effects, 
and induction of various genes (see [l]). Several of these 
effects of TNF have been shown to be potentiated by 
interferons 12-71. The receptors for TNF have been re- 
ported to be induced by IFN-y [S-13], a process that 
may play a role in their synergistic biological response. 
Recently the cDNA for two different TNF receptors 
with approximate molecular masses of 60 kDa ($9) 
and 80 kDa (~80) have been isolated [ 14-171. It has been 
shown that the p60 form of the receptor is primarily 
expressed on epithelial cells whereas the ~80 form is 
displayed by myeloid cells [18]. Furthermore, a recent 
repon suggests that these receptors mediate distinct dg- 
nab [ 193. How IFN-y affects each type of TNF receptor 
is not known. Therefore, we investigated the effect of 
IFN-y on the cell surface expression of TNF receptors 
in epithelial and myeloid cells by using antibodies pe- 
cific to each type of receptor. 
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2. I. Materials 
Bacteria-derived recombinant human TNFa and IFN-7, purified 
to homogeneity with specific activities of5 x IO’ units/mg and 1 x 10’ 
unitsimg. respectively, were kindly provided by Gencntech, Inc., 
South San Francisco, CA. The highly purified form of the recombi- 
nant cxtracellular domains of TNF receptors p6O (TNF rceeptor I) 
and ~80 (TNF receptor II) with molecular masses of 30 kDa and 40 
kDa, respectively, were kindly provided by Dr. Tadnhiko Kohuo of 
Synergen. Boulder. CO. The soluble forms of these receplom have 
been previously characterized [In. Polyclonal antibodies in rabbits 
were r:listc! ag+nst cztri-f! type of receptor and purified by reccptor- 
aftinity chromatography. 
All cell lines employed in these studies were obtained from the 
American Type Cell Culture Collection (Rockville. MD). Primary 
human foreskin fibroblasw at early passages were kindly supplied by 
Dr. Olivia Smith of Baylor College of Medicine, Houston, TX. The 
myeloid cell lines, KG I and KG la were kindly provided by Dr. P. 
Pantazis of the Stehlin Foundation, Houston, TX, Cells were Brown 
in RPM1 lG40 medium supplemented with 10% fetal calf serum (FCS) 
and gcntamycin (,SO~ug/ml). The cells were seeded a[ a density of 1 x 
IO’ cells/ml in T-25 flasks (Falcon 3013. Becton Dickinson Labware, 
Lincoln Park, NJ) containing 10 ml of medium and grown at 3?‘C in 
an atmosphere of 95% air and 5% CO:. Cell cultures were split every 
3 or -1 days. 
2.3. Receptor-bimhhg ussoy 
Recombinant human TNF was labeled with Na ‘“1 using the IO- 
DOOEN procedure as described previously [S]. The specific a livity 
of lab&d TNF was 30 rCi/~g. Binding assays were pcrfoned using 
the 96.well method as described 1211. Briefly. eells (0.2-I x 100 oells/ 
well) were incubated in a bindini buffer (KPMI 1640 supplemented 
with 10% FCS) in either l2-well plates or 12 mm x 75 mm polypro- 
pylene tubes with IsI-lab&d ligand and with or without a IOO-fold 
e~cesa of unlabeled ligand for 2 h at 4OC in a total volume of 0.1-0.5 
ml. Thereafter. eells were washed three times with 0.5 ml of ice-cold 
washing buffer (PBS containing 0.1% BSA). Cell-bound radioactivity 
was then detcrmincd by a Packard gamma counlcr (model CD 5010). 
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3. RESULTS 
3.1. Induction of cell-surface expressiorl of TNF recep 
rors by IFN-y 
We first examined the effect of different concentfa- 
tions of lFN-y on the cell surface expression of TNF 
receptors on HeLa, an epithelial tumor cell line. IFN-y 
induced TNF receptors in a dose-dependent manner, 
and the optimum induction occured at a 100 @ml con- 
centration of the cytokine after 6 h incubation (Fig. I). 
The induction of TNF receptors in HeLa cells was fur- 
ther analyzed for receptor-density and -affinity by 
Scatchard analysis. There was approximately a two-fold 
induction in TNF receptor number without any signifi- 
cant change in the receptor affinity (Fig. 2). 
3.2. Indwrion of TNF receptors by IFN-y occurs on both 
epitlzelial and myeloid cells 
.& has been shown that the p60 form of the TNF 
receptor is mainly expressed by epitbelial cells, whereas 
the ~80 form is expressed by myeloid cells [I 81. To 
deter.mine the type of receptor induced by IFN-y, we 
examined its effects on a wide variety of epithelial and 
myeloid cell lines. The TNF receptor could be induced 
by IFN on most myeloid and epithelial cell lines but to 
a variable degree (Table I). Under identical conditions, 
among myeloid cell lines, the highest induction was ob- 
served in HL-60, whereas HeLa cells showed maximum 
increase among epithelial cell lines. Interestingly, some 
epithelial cell lines such as ZR-75-l and Hep G2 showed 
a significant reduction in the expression of cell surface 
receptors after IFN treatment. 
3.3. Botlt thep6O arld thep8OJorms ofthe TNF receptors 
are induced by IFN-y 
The expression of p60 and p80 receptors by epithelial 
and myeloid cells is not exclusive; most cell types ex- 
press both types of receptor in different proportions. 
Thus the induction of TNF receptors observed above 
could be because of induction of either the p60 or ~80 
form of the receptor. In order to determine the type of 
receptor induced, we employed receptor-specific anti- 
bodies to confirm the induction of each type of receptor 
by IFN-y on myeloid cells (e.g. HL-60 and K-562) and 
epithelial cells (e.g. HeLa). The results of these experi- 
ments are shown in Table 11. Both HL-60 and K-562 
cells displayed both p6O and p80 forms of the receptor 
and both of these receptors were induced by treatment 
of cells with IFN. The induction of receptors in HeLa 
cells was primarily due to the p60 form. 
3.4. IFN-a and IFN-,6 cun also induce both types of TNF 
receptors 
TNF’ receptors were also induced by other interfer- 
ons. The results of these xperiments shown in Table III 
indicate that in HeLa cells both IFN-a and IFN-p in- 
creased the cell surface xpression of TNF receptors by 
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Fig. I. Induction orcell surface expression ofTNF receptors by differ- 
ent concentrations of IFN-y in HeLa cells. Cells (2 x 105) were incu- 
bated with IFN-y for 6 h, washed, and tested for TNF receptors as 
indicated in section 2. All determinations were made in triplicate. 
35% and. 153% respectively, compared with 72% by 
IFN-r. However, the induction of receptors in K-562 
and I-IL-60 by IFN-a and IFN-p was less F?rrsnour!ced 
than that by IFN-y. 
Table 1 
Induction of pG0 and ~80 forms of the TNF receptors on different 
epithelial and myeloid cell lines by interferon-y 
Cell lines Specitic binding (cpm) Percent 
induc- 
None IFN-y lion 
Myeloid Cells 
Promyelocyiic (HL-60) 5,306_CS34 9,SS9f 1,329 I80 
Promonocytic lcukemias (TNP-1) 1,354 ?: 234 1,572 f 95 I38 
Acute myelogenous leukemia 
[KG-I‘) 1.47Sf342 1.914k2 130 
Erythroblastoid (K-562) a;‘6527777 10;540f 1,054 129 
Histocytic lymphoma (U-937) 13,910 f 904 17,160 P 87 I I23 
Lcukcmia (KG-la) 1,439&34S 1,501 A204 104 
Epitheliol Cells 
Epitheloid carcinoma (HeLa) 3,309;230 5,644P413 170 
Fibroblasts (FS) 69524 I,143247 lG4 
Breast carcinoma (MCF-7) 7022 1s 99627 142 
Epidcrmoid carcinoma (A-43 I) I ,013 P 74 1,242 f 32 123 
Adenocarcinoma (SK-BR3) 54627 7OOk48 I28 
Cervical carcinoma (ME-180) 
Breast carcinoma IBT-2ORI 
Adenocarcinoma (&CARj 
Melanoma (RPMI-7951) 
Melanoma (A-375) 
Heptomn (Hep G2) 
Breast carcinoma (ZR-75-l) 
8082 I7 929 f 67 II5 
447 f 40 520+ I2 II6 
570 + 379 612?8 107 
540 f 78 471-r-42 81 
1,017?: I II 970274 95 
1,646 k 80 I,056220 64 
736 & 204 359*35 49 
0.2-l x IO6 cells were treated overnight with IFN-r (IO0 @ml) at 
37OC and then washed and examined for TNF receptors as indicated 
in section 2, All determinations were made in triplicate. 
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Fig, 2. The TNF binding curve (upper panel) and Scatchard analysis 
(!~er p:;cel) of the ccl! surface receptors on HeLa cells before 
(square) nnd afux (diamond) IFN-r treatment. Cells (2 x IO’/wcll) 
were trcnted with IFN (IO0 ngfml) for 6 h at 37’C and then binding 
was determined at 4’C as described in section 2. All determinations 
were made in triplicate. 
Table II
Percent induction of the pS0 and ~60 forms of TNF receptors on 
human epithelial and myeloid ccl1 lines by human interferon-y 
Cell lines Percent induction 
Total D60 a80 
Mycloid cel!s 
l-IL-60 
K-562 
Epithclial cells 
Heta 
I55 146 135 
192 190 229 
IS4 150 0 
,3.2-l x 106cells wcrc incubated with IFN-y (100 @ml) overnigkt and 
tker! washed. Cells were then preincubated with either pre-immune or 
anti-pG0 (for p60 receptor) or anti-p80 antibodies for 1 h at 37OC and 
then examined for remaining TNF receptors. TNF binding observed 
in the presence 0r pre-immune serum was set al 100%. 
4. DISCUSSION 
Previously our laboratory and several others have 
demonstrated that IFN-y can induce TNF receptors 
[S-13]. These studies were carried out when the exis- 
tence of two tyPe of TNF receptors was not known. 
Recently, two distinct ypes of TNF receptor, with mo- 
lecular sizes of 60 kDa (~60) and 80 kDa (PSO), have 
been identified [M-18]. It has been shown that these two 
receptors are independently regulated and also they 
transduce distinct signals [191. The antiproliferative sig- 
nals of TNF are thought o be mediated through the p60 
form of the receptor, whereas the pS0 form, which is 
considered species-specific, mediates the proliferative 
signal [23]. How these two type of receptors are regu- 
lated by IFN-y is not known. In the present report, we 
demonstrate that TNF receptors are induced by IFN-y 
on epithelial cells (which express primarily the ~60 form 
of the receptor) and on myeloid cells (which mainly 
express the p80 form of the receptor). Antibodies spe- 
cific to each type of receptor confirmed that both types 
of TNF receptor are induced by IFN-y. The induction 
of cell surface expression of the TNF receptor was also 
observed with IFN-a and IFN-p. 
In spite of induction of cell-surface xpression of both 
TNF receptors, previous reports showed a lack of effect 
of IFN-y on the mRNA transcript of the ~60 receptor 
[15,27]. We confirmed these reports during our study 
Table III 
Induction of cell-surface xpression of TNF receptors by various 
interferon5 on different cells 
Cell lines IFNs Specific binding (cpm) 
Receptor neutralization 
HeLa 
Pre-immune And-p60 Anti-p80 
None 41 I *_ 108 (100) 39 +- 7 429 k I10 
IFN-Q S56f 85(135) 121 k 2 1,227 * 107 
IFN-D 1,040 f 5 (253) 84k74 762+&l 
TM-7 709178(172) 452 10 6oOf20 
K-562 None G,790 + 638 (100) 3,793 + 274 2,243 2 17 
1FN-a 7,621 i45(112) 4,327*36 1.708 f 135 
lFW 8.050 + 23 ( I 18) 5,335 + 224 I.970 4 28 
ll=N-T 9.955 4 238 (147) 6.514 4 63 2,845 + 133 
HL-60 None 8.897 2 77 (WI) 4,575 2 SO3 2,500 + 10 
IFN-LZ 9,670 f 39 (108) 5.375 f 188 2,170 + 2S 
IFN-/9 9,575 -c IS (107) 6,602 P 91 2,1&l + 80 
IFN-r I 1.967 + 220 (134) 8.S13 f 77 2.511 f 11 
Cells (1 x IO” for K-562 and HL-60, and 0.2 x I@ for HeLa) were 
incubated with either IFN-a or IFNQ or IFN-y (100 n@nl) ovcmighl 
at 37OC. Thereafler, cells were washed and examined for p6O and ~80 
form of the receptors by preincubadon with either pre-immune, or 
anti-p60 or anti-p80 antibodies for 1 k at 37’C. and then specific TNF 
binding determined, as described insection 2. Numbers in parcntkxs 
indicate 96 induction by a given IFN when cells lreated with pre- 
immune serum are expressed as 100%. 
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also (data not shown), These results uggest adifference 
in the regulation of the two receptors between the tran- 
scriptional and translational level, 
Since the ~60 form of the TNF receptor has been 
shown to be involved in the antiproliferative effects of 
the cytokines, it is possible that the synergistic increase 
in the antiproliferative ffect by IFN-y is due to the 
induction of the p60 form of the receptor. However, 
some of the earlier studies suggest that the induction of 
receptors alone is not sufficient for a synergistic re- 
sponse [20,24]. Since the ~80 form of the TNF receptor 
has been implicated in the proliferation of T cells and 
thymocytes, whther these effects of TNF are also en- 
hanced by IFN-y is not known. It has been shown that 
for proliferation of normal human flbroblasts, however, 
the signal is mediated through the p60 form of the recep- 
tor [25]. Fibroblast proliferation induced by TNF has 
been shown to be inhibited by IFN-y [26]. These results 
also suggest hat the induction of receptor alone is not 
sufficient for the proliferative response. Overall, our 
results shown here demonstrate that all three IFNs can 
induce the cell surface xpression of both types of TNF 
receptor. 
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